Researches suggest transcription of p300 is controlled by myocyte-specific enhancer factor 2 (MEF2) and GATA4 (zinc-finger transcription factor, indicating cardiac hypertrophy, and increasing DNA accessibility), and this transcript control process is critical for cardiac development (24, 25) and heart failure (26–28). Here, EP300 is linked to cardiac hypertrophy.